(Virtual Event) International Conference on Molecular Imaging and Clinical PET–CT in the Era of Theranostics (IPET-2020) - Programme - Day 2

Wednesday, 25 November 2020 #IPET2020

CLINICAL SESSION 3: Head and Neck Cancers

Chairperson: Gopinath Gnanasegaran, Royal Free London NHS Foundation Trust, UK

IAEA Coordinator: Enrique Estrada 

10:00 - 10:20

Role of CT and MRI - Soraya Robinson, ESR

10:20 - 10:40

Role of PET/CT - Wim Oyen, EANM

10:40 - 10:55

Live Q/A

PLENARY SESSION 2: Education, Ethics and Leadership

Chairperson: Stefano Fanti, EANM

IAEA Coordinator: Diana Paez 

10:55 - 11:15

Ethics and Leadership - Sobhan Vinjamuri, Royal Liverpool and Broadgreen University Hospitals NHS Trust, UK

11:15 - 11:35

Challenges in Theranostics: Major Role of Education and Training - Jean-Luc Urbain, WFNMB

11:35 - 11:55

Challenges in Education and Research in Nuclear Medicine - Andrew Scott, Olivia Newton-John Cancer Research Institute, Australia

11:55 - 12:05

Live Q/A

ABSTRACT SESSION 3

12:05 - 12:35

Chairperson: Jun Hatazawa, AOFNMB

IAEA Coordinator: Pilar Orellana 

Combined versus subtraction-only technique in parathyroid scintigraphy - Julius Sebikali Mugisha, Uganda (55*)

Progressive accumulation of radiolabelled white cells in scans performed for suspected vascular prosthetic graft infections - Jeffrey Adam Jooma, Malawi (101*)

F-18 FDG PET/CT in electrical status epilepticus in sleep (ESES) - An emerging role - Srivastava Madhur Kumar, India (98*)

*Abstract number

INTERACTIVE SESSION 2: PET/CT

IAEA Coordinator: Enrique Estrada

12:35 - 12:55

Pearls and Pitfalls in PET/CT - Ora Israel, FSNMMI and Israel Institute of Technology - Technion Haifa, Israel

12:55 - 13:15

Appropriate Use of PET/CT in Paediatrics - Barry Shulkin, St. Jude Children’s Research Hospital, USA

CLINICAL SESSION 4: Lymphomas

Chairperson: Arturo Chiti, Humanitas Research Hospital - Humanitas University, Italy

IAEA Coordinator: Pilar Orellana 

13:15 - 13:35

What the Clinician Needs to Know - Samir Nabhan, Federal University of Parana, Brazil

13:35 - 13:55 

RT Planning - Berardino de Bari, University of Neuchâtel, Switzerland

13:55 - 14:25

Role of PET/CT in Staging and Evaluation of Treatment Response - Juliano Cerci, ALASBIMN

14:25 - 14:40

Live Q/A 

14:40 - 14:50

Break

CLINICAL SESSION 5: Gynaecological Cancers

Chairperson: Ora Israel, FSNMMI and Israel Institute of Technology - Technion Haifa, Israel

IAEA Coordinator: Olivier Pellet 

14:50 - 15:10

Role of PET/CT in Gynaecological Cancers - Giuliano Mariani, University of Pisa, Italy

15:10 - 15:30

Role of PET/CT in Breast Cancer - Rathan Subramaniam, University of Otago, New Zealand

15:30 - 15:45

Live Q/A

ABSTRACT SESSION 4

15:45 - 16:25

Chairperson: Mohamad Haidar, ARSNM

IAEA Coordinator: Olivier Pellet 

Role of FDG-PET/CT in the evaluation and staging of hepatocellular carcinoma - Shahzad Qasim, Pakistan (106*)

Correlation between 18F-FDG brain uptake patterns and immunotherapy treatment outcome in advanced melanoma patients - Mauro Namías, Argentina (84*)

F18PSMA 1007 PET/CT in localizing recurrence in biochemistry relapse in prostate cancer - Mariela Agolti, Argentina (150*)

Usefulness of FDG PET/CT in a very rare pulmonary artery leiomyosarcoma: a case report - Tawika Kaewchur, Thailand (54*)

*Abstract number